Verywell Health on MSN1mon
Understanding AVNRT (Atrioventricular Nodal Reentrant Tachycardia)
It is a common type of what's called paroxysmal supraventricular tachycardia (PSVT), a cardiac arrhythmia that often affects ...
Nasdaq3mon
FDA Issues Complete Response Letter for Etripamil for PSVT
“We are deeply disappointed by the CRL but remain committed to the potential of CARDAMYST as a novel treatment option that can help patients with PSVT. Our team is evaluating the feedback ...
Monthly Prescribing Reference3d
FDA Decision on Etripamil Nasal Spray Delayed Due to Nonclinical Issues
Findings showed a higher proportion of patients in the etripamil group achieved PSVT conversion to sinus rhythm within 30 minutes compared with those who received placebo. Etripamil was also ...
Nasdaq17d
Milestone Pharmaceuticals Reports FDA PDUFA Review Date for CARDAMYST™ Nasal Spray Targeting PSVT, Plans for Mid-2025 Launch
"We are focused on the potential FDA approval for CARDAMYST and the opportunity to help the millions of patients suffering from PSVT,” said Joseph Oliveto, President and Chief Executive Officer ...